Considering this assumption, in this study we investigated the ability of nucleic acid analogs targeted against MYCN transcription to impair viability of blast cells from two pediatric patients with T-ALL overexpressing MYCN. The gene discussed is MYCN; the disease is acute lymphoblastic leukemia.